ResearcherUniversity of MichiganActive in the last 2 years

Eugene W. Gerner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9906-8501; OpenAlex author ID A5108364106; NIH RePORTER profile ID 1882170. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2012: 1 grant · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Grants 1

Translational Control by eIF3f in Pancreatic Cancer R03CA158895 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hwudaurw Chen · 1 shared paper, 2026 · strength 0.39
- Paper Difluoromethylornithine modulates mutant K-RAS signaling pathways in pancreatic cancer cells. DOI 10.1007/s00726-026-03559-5 ↗
Natalia A. Ignatenko · 1 shared paper, 2026 · strength 0.39
- Paper Difluoromethylornithine modulates mutant K-RAS signaling pathways in pancreatic cancer cells. DOI 10.1007/s00726-026-03559-5 ↗
Jiaqi Shi · 1 shared paper, 1 shared grant, 2012–2013 · strength 0.18
- Grant Translational Control by eIF3f in Pancreatic Cancer R03CA158895 ↗
- Paper Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. DOI 10.1158/0008-5472.can-12-3287 ↗
Fushi Wen · 1 shared paper, 2013 · strength 0.05
- Paper Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. DOI 10.1158/0008-5472.can-12-3287 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.